Business Wire

Forrester’s Technology & Security Predictions 2025: Tech Leaders Will Triple The Adoption Of AIOps To Reduce Technical Debt

22.10.2024 16:23:00 CEST | Business Wire | Press Release

Share

According to Forrester’s (Nasdaq: FORR) 2025 technology and security predictions, 75% of technology decision-makers will see their technical debt rise to a moderate or high level of severity by 2026. This will be due to the rapid development of AI solutions, which are adding complexity to IT landscapes.

To stem the tsunami of technical debt, in 2025, tech leaders will triple the adoption of AI for IT operations (AIOps) platforms, which deliver contextually aware data to enhance human judgment, automatically remediate incidents, and improve business outcomes. While AIOps is the future, IT leaders aiming to run a high-performance IT organization will also need to invest in building the right culture, data, architecture, and security practices to accelerate business growth.

Forrester’s technology and security predictions analyze the dynamics and emerging trends to watch for in the year ahead. These insights help leaders and their teams prepare for future challenges and take advantage of new opportunities to thrive in 2025. Topics include: artificial intelligence; automation; tech leadership; cloud computing; tech infrastructure and operations; enterprise software; software development; and cybersecurity, risk, and privacy.

Highlights from Forrester’s 2025 technology and security predictions include the following:

  • The European Union will fine a generative AI provider for the first time under the EU AI Act. With the EU AI Office and data protection authorities joining forces, a general-purpose AI (GPAI) model’s provider will receive the first fine for violating the EU AI Act in 2025. As with the General Data Protection Regulation, the EU AI Act applies to entities that operate in the EU as well as those that supply AI systems or GPAI models to the EU, regardless of where they’re headquartered.

“In 2024, technology and security leaders ran pilots across their enterprises to explore innovative applications of AI,” said Sharyn Leaver, chief research officer at Forrester, “but not all AI initiatives yielded the intended business outcomes. While this bold experimentation will continue in 2025, leaders will also focus heavily on putting the lessons learned into practice to ensure that their investments deliver true business value.”

Resources:

About Forrester

Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We help leaders across technology, customer experience, digital, marketing, sales, and product functions use customer obsession to accelerate growth. Through Forrester’s proprietary research, consulting, and events, leaders from around the globe are empowered to be bold at work — to navigate change and put their customers at the center of their leadership, strategy, and operations. Our unique insights are grounded in annual surveys of more than 700,000 consumers, business leaders, and technology leaders worldwide; rigorous and objective research methodologies, including Forrester Wave™ evaluations; and the shared wisdom of our clients.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241022193804/en/

Contacts

Press:
Hannah Segvich
hsegvich@forrester.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press Release

Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob

Yubico ansluter sig till European Cyber Security Organisation (ECSO)1.7.2026 06:00:00 CEST | Pressmeddelande

Yubico, ledande inom nätfiskeresistent autentisering och skapare av YubiKey, den hårdvarubaserade passkeyn, meddelar idag att företaget officiellt har antagits som medlem i European Cyber Security Organisation (ECSO), en paneuropeisk offentlig-privat sammanslutning som arbetar för att stärka europas cybersäkerhetsekosystem. Medlemskapet gör det möjligt för Yubico och ECSO att påskynda sitt gemensamma arbete för nätfiskeresistent autentisering och moderna standarder för digital identitet i hela Europa. ECSO välkomnar Yubico vid ett avgörande läge, när organisationer i Europa och globalt försöker hantera en omfattande våg av sofistikerade attacker mot inloggningsuppgifter. Attackerna kan enkelt kringgå traditionella lösenord och äldre, nätfiskekänsliga lösningar för multifaktorautentisering (MFA). I en tid då AI-drivna nätfiskeattacker mot digitala identiteter har ökat med över 200 procent i Europa understryker medlemskapet Yubicos roll som en betrodd ledare och innovatör inom cybersäker

EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press Release

EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press Release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press Release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye